Search Results 821-830 of 19752 for Hepatitis+C

  1. Publications - Maheen Z. Abidi, M.B.B.S., M.D. - Mayo Clinic

    Hepatitis B transmission/reactivation associated with Hepatitis B core antibody and Hepatitis C nucleic acid testing positive organs: A report from the ...

  2. A Study To Assess The Effectiveness And Safety Of Rilonacept Treatment In Subjects With Recurrent Pericarditis - Mayo Clinic

    Has a history of positive or intermediate results for hepatitis B surface antigen, hepatitis B core antibody, or hepatitis C virus antibody at screening.

  3. CTX131 in Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

    ... hepatitis B virus or hepatitis C virus infection. Subjects with prior history of hepatitis B or C infection who have documented undetectable viral load (by ...

  4. Study Evaluating the Safety, Tolerability, and Effectiveness of EDP-305 in Subjects with Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    Note: subjects previously infected by chronic hepatitis C and treated with direct acting antivirals (DAAs) with sustained virologic response (SVR) for at least ...

  5. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

    ... hepatitis B or C are permitted. Subjects positive for hepatitis B surface antigen and/or anti-hepatitis B core antibody with negative viral load are ...

  6. Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer - Mayo Clinic

    ... hepatitis B surface antigen [HBsAg] reactive) and/or active hepatitis C infection (e.g., hepatitis C virus [HCV] ribonucleic acid [RNA] qualitative is ...

  7. Mayo Clinic Launches Whole Genome Breast Cancer Study

    Transmission Of Hepatitis C Infection To Patients · Pairing Patients With Mouse Avatars For Whole Genome Breast Cancer Study. Related Articles. Mayo Clinic ...

  8. A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma - Mayo Clinic

    Diagnosed with HIV, Hepatitis B, or Hepatitis C infection. 11. Treatment with non-oncology vaccines for the control of infectious diseases (i.e., HPV ...

  9. Stem Cell Coated Fistula Plug in Patients With Crohn's RVF - Mayo Clinic

    Specific exclusions; Evidence of hepatitis B, C, or HIV; History of cancer including melanoma (with the exception of localized skin cancers); Investigational ...

  10. Analytic Treatment Interruption (ATI) to Assess HIV Cure - Mayo Clinic

    Evidence of viral replication with Hepatitis C virus (HCV), together with evidence of any hepatic fibrosis or inflammation. Such patients should be offered ...